Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: calcium

ACR Convergence graphic

New Clinical Insights into the Pathogenesis, Diagnosis & Treatment of Calcium Pyrophosphate Arthritis

Carina Stanton  |  December 17, 2020

New diagnostic approaches combined with new evidence about pathogenesis are providing opportunities to help rheumatologists manage calcium pyrophosphate deposition disease.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020Calcium pyrophosphate (CPP) arthritiscalcium pyrophosphate deposition diseasemeeting reports

Dietary Calcium Intake Not Associated with Bone Loss

Lara C. Pullen, PhD  |  April 15, 2019

Postmenopausal women are often told to consume more than 1,500 mg of calcium daily to reach neutral bone balance. But new research suggests this recommendation should be revised, finding no connection between dietary calcium intake and postmenopausal bone loss…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone lossbone mineral density (BMD)calciumDietFracturesOsteoporosis

Many in U.S. Take More Calcium Supplements than Necessary

Lisa Rapaport  |  March 30, 2018

(Reuters Health)—Some adults in the U.S. who use supplements to get their daily requirement of calcium are taking higher doses than necessary, a recent study suggests. Researchers examined nationally representative survey data on dietary habits and vitamin and supplement use collected between 1999 and 2014 from 42,038 adults. About one in 20 adults got a…

Filed under:Drug Updates Tagged with:calcium supplementsPamela Lutsey

Vitamin D, Calcium Supplements May Not Lower Fracture Risk

Lisa Rapaport  |  January 1, 2018

(Reuters Health)—Older adults who take vitamin D and calcium are no less likely to break their hips or other bones than peers who don’t use these supplements, a research review suggests. Researchers examined data from 33 previous trials with a total of more than 51,000 people aged 50 or older who were living in the…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone mineral density (BMD)calciumFractureship fractureOsteoporosisosteoporosis treatmentsVitamin D

Predictive Value of Imaging Studied for Calcium Crystal Deposition in Rheumatic Diseases

Thomas R. Collins  |  September 17, 2017

MADRID—Calcification in osteoarthritis (OA) involves a series of pathways and interactions that feed off each other in a process that bears some resemblance to the transformation of cartilage to bone that takes place in the embryonic stage of human development, a researcher said here at the 2017 Annual European Congress on Rheumatology (EULAR). “My hypothesis…

Filed under:ConditionsGout and Crystalline ArthritisOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Annual European Congress of Rheumatologycalcificationcalciumcalcium pyrophosphateDiagnosisEULARimagingOsteoarthritisradiographyResearchultrasonographyX-ray

Calcium Crystal Deposition in Rheumatic Diseases: Mechanisms & Evaluation of Calcium Crystal Deposits Explored

Thomas R. Collins  |  August 15, 2017

MADRID—Calcification in osteoarthritis (OA) involves a series of pathways and interactions that feed off each other in a process that bears some resemblance to the transformation of cartilage to bone that takes place in the embryonic stage of human development, a researcher said here at the 2017 Annual European Congress on Rheumatology (EULAR). “My hypothesis…

Filed under:ConditionsEULAR/OtherMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:cartilageEULARimagingosteoarthritis (OA)TendinopathyUltrasound

How to Recognize Inborn Errors of Immunity

Vanessa Caceres  |  May 13, 2025

Inborn errors of immunity may not always be easy to recognize, but rheumatologists should look out for them. Dr. Bharat Kumar shares his insights.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ACR on Airimmune deficiencyinborn errors of immunitypatient carepodcast

Cilnidipine Receives Orphan Drug Status to Treat Systemic Sclerosis

Michele B. Kaufman, PharmD, BCGP  |  May 9, 2025

Based on research showing improved signs and symptoms of systemic sclerosis in patients taking cilnidipine vs. placebo, the FDA granted orphan drug designation for the agent.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSystemic Sclerosis Tagged with:AISA-021cilnidipineFDASScsystemic sclerosis (SSc)U.S. Food and Drug Administration (FDA)

Skin disorder, pepper appearance from scleroderma, autoimmune disease male hand Skin disorder pepper appearance from vitiligo,scleroderma raynaud, medical concept autoimmune disease. Credit: Adobe Stock | Trsakaoe

Through Thick & Thin: Updates in Scleroderma

Jason Liebowitz, MD, FACR  |  January 22, 2025

Pulmonary hypertension and Raynaud’s phenomenon are just some of the symptoms patients with systemic sclerosis (SSc) may experience. Here are insights into the diagnosis and management of SSc.

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Sclerosis Tagged with:interstitial lung disease (ILD)pulmonary hypertensionRaynaud’s phenomenonSclerodermaSSc-ILDsystemic sclerosis (SSc)

The Great Imitator: Updates on Sarcoidosis

Jason Liebowitz, MD, FACR  |  January 15, 2025

Michelle Sharp, MD, MHS, shared insights into the complexities of sarcoidosis, describing how she evaluates, diagnoses and treats patients.

Filed under:ConditionsEULAR/OtherMeeting ReportsOther Rheumatic Conditions Tagged with:neurosarcoidosispatient carepulmonary sarcoidosisSarcoidosis

  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences